Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penthrox in acute trauma pain
NCT03798899Phase 4Completed
- Sponsor
- Mundipharma
- Start
- May 2018
- Primary completion
- Dec 2018
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute pain comparing Penthrox + SoC with Placebo + SoC (2 arms). Primary endpoint: Time until pain relief at 2 hours. Started May 2018; status: completed.
02
Drugs
methoxyflurane
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03798899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03798899.